Clinical Trial

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2021-09-20; most recent amendment 2026-07-15.
Status change: Not Yet Recruiting → Recruiting 2022-10-17
Trial Details
NCT Number NCT05053867
Lead Sponsor M.D. Anderson Cancer Center
Conditions Pulmonary Hemorrhage, Cancer
Enrollment 60 participants
Start Date 2022-10-14
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16